Cargando…

CEACAM1 Promotes Melanoma Cell Growth through Sox-2()()

The prognostic value of the carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) in melanoma was demonstrated more than a decade ago as superior to Breslow score. We have previously shown that intercellular homophilic CEACAM1 interactions protect melanoma cells from lymphocyte-mediated elimin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortenberg, Rona, Galore-Haskel, Gilli, Greenberg, Ilanit, Zamlin, Bella, Sapoznik, Sivan, Greenberg, Eyal, Barshack, Iris, Avivi, Camila, Feiler, Yulia, Zan-Bar, Israel, Besser, Michal J., Azizi, Ester, Eitan, Friedman, Schachter, Jacob, Markel, Gal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198694/ https://www.ncbi.nlm.nih.gov/pubmed/24931667 http://dx.doi.org/10.1016/j.neo.2014.05.003

Ejemplares similares

SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells
por: Ashkenazi, Shira, et al.
Publicado: (2016)

Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients
por: Sivan, Sapoznik, et al.
Publicado: (2012)

Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanoma
por: Galore-Haskel, Gilli, et al.
Publicado: (2017)

Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma Cells()()
por: Kfir-Elirachman, Karin, et al.
Publicado: (2018)

CEACAM1 and MICA as novel serum biomarkers in patients with acute and recurrent pericarditis
por: Markel, Gal, et al.
Publicado: (2016)

Novel Anti-Melanoma Immunotherapies: Disarming Tumor Escape Mechanisms
por: Sapoznik, Sivan, et al.
Publicado: (2012)

Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy
por: Ortenberg, R., et al.
Publicado: (2015)

A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme
por: Galore-Haskel, Gilli, et al.
Publicado: (2015)

Nicotinamide Inhibits Vasculogenic Mimicry, an Alternative Vascularization Pathway Observed in Highly Aggressive Melanoma
por: Itzhaki, Orit, et al.
Publicado: (2013)

Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns
por: Haik, Josef, et al.
Publicado: (2015)

Immune co-culture cell microarray – a feasible tool for high-throughput functional investigation of lymphocyte–cancer interactions
por: Baruch, Erez Nissim, et al.
Publicado: (2020)

ADAR1-mediated regulation of melanoma invasion
por: Nemlich, Yael, et al.
Publicado: (2018)

Regulation of Cancer Aggressive Features in Melanoma Cells by MicroRNAs
por: Greenberg, Eyal, et al.
Publicado: (2011)

miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1
por: Cohen, Ronit, et al.
Publicado: (2015)

CEACAM1-Mediated Inhibition of Virus Production
por: Vitenshtein, Alon, et al.
Publicado: (2016)

Development of Allogeneic NK Cell Adoptive Transfer Therapy in Metastatic Melanoma Patients: In Vitro Preclinical Optimization Studies
por: Besser, Michal J., et al.
Publicado: (2013)

Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex
por: Greenberg, Eyal, et al.
Publicado: (2014)

Mutagen-Specific Mutation Signature Determines Global microRNA Binding
por: Greenberg, Eyal, et al.
Publicado: (2011)

Natural Killer Lysis Receptor (NKLR)/NKLR-Ligand Matching as a Novel Approach for Enhancing Anti-Tumor Activity of Allogeneic NK Cells
por: Markel, Gal, et al.
Publicado: (2009)

Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation
por: Seliktar-Ofir, Sivan, et al.
Publicado: (2017)

Reduced culture temperature attenuates oxidative stress and inflammatory response facilitating expansion and differentiation of adipose-derived stem cells
por: Tirza, Gal, et al.
Publicado: (2020)

CEACAM1 is a direct SOX10 target and inhibits melanoma immune infiltration and stemness
por: Abou-Hamad, John, et al.
Publicado: (2022)

Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers
por: Blumenthal, Rosalyn D, et al.
Publicado: (2007)

Role of CEACAM1 and CEACAM20 in an In Vitro Model of Prostate Morphogenesis
por: Zhang, Hui, et al.
Publicado: (2013)

T cell-mediated elimination of cancer cells by blocking CEACAM6–CEACAM1 interaction
por: Pinkert, Jessica, et al.
Publicado: (2021)

Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy
por: Yunger, Sharon, et al.
Publicado: (2019)

CEACAMs: their role in physiology and pathophysiology
por: Kuespert, Katharina, et al.
Publicado: (2006)

Soluble CEACAM8 Interacts with CEACAM1 Inhibiting TLR2-Triggered Immune Responses
por: Singer, Bernhard B., et al.
Publicado: (2014)

Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis
por: Burgos, Miguel, et al.
Publicado: (2022)

Heterogeneity of CEACAM5 in breast cancer
por: Bechmann, Marc B., et al.
Publicado: (2020)

Interactions of pathogenic Escherichia coli with CEACAMs
por: Sheikh, Alaullah, et al.
Publicado: (2023)

CEACAM expression in an in-vitro prostatitis model
por: Kube-Golovin, Irina, et al.
Publicado: (2023)

Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6
por: Chan, C.H.F., et al.
Publicado: (2007)

Homophilic adhesion and CEACAM1-S regulate dimerization of CEACAM1-L and recruitment of SHP-2 and c-Src
por: Müller, Mario M., et al.
Publicado: (2009)

Binding of Candida albicans to Human CEACAM1 and CEACAM6 Modulates the Inflammatory Response of Intestinal Epithelial Cells
por: Klaile, Esther, et al.
Publicado: (2017)

Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy
por: Nissani, Abraham, et al.
Publicado: (2021)

Reversal of obesity development in Ceacam1 ( −/− ) male mice by bone marrow transplantation or introduction of the human CEACAM1 gene
por: Zhang, Zhifang, et al.
Publicado: (2022)

CEACAM6 gene expression in intrahepatic cholangiocarcinoma
por: Ieta, K, et al.
Publicado: (2006)

CEACAM1: Expression and Role in Melanocyte Transformation
por: Turcu, Gabriela, et al.
Publicado: (2016)

CEACAM1 promotes vascular aging processes
por: Kleefeldt, Florian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2tsq3h2nuh8jme7qdtbbok956c